effects of semaglutide on chronic kidney disease flow trial renal outcomes 2024 In the trial, researchers assessed whether the glucagon-like peptide semaglutide in chronic kidney disease

Some patients report: Changes in stool consistency and frequency Increased bloating and gas A shift in gut bacteria that affects digestion Because GLP-1 medications influence bile production, the way fats are broken down and absorbed may change, sometimes leading to foul-smelling gas production

For more Health articles, visit www.foxnews.com/health "By reducing the volume of fat cells in the body, we reduce all these inflammatory cytokines," she said

By screening for conditions like multiple endocrine neoplasia syndrome and monitoring your progress, we help you reach your goals while protecting your long-term health

First use-test on a small part of the skin

Vitamin C Benefits: Provides antioxidant protection, supports immune system function, and aids in collagen synthesis (important during body composition changes)

Abbas A, Amin HMA